How to Run a SARMs Cycle: Step-by-Step Guide for UAE Athletes (2026)

How to Run a SARMs Cycle: Step-by-Step Guide for UAE Athletes (2026)

Medical disclaimer: This article is for informational purposes only and does not constitute medical advice. SARMs are not approved by the FDA or UAE Ministry of Health for human use. Consult a licensed physician before using any performance compound. SARMs are prohibited in competitive sport under the WADA Prohibited List (S1.2).  |  Last updated: March 2026

A 2022 review published in Drugs (Thevis et al.) found that SARMs-related adverse event reports to the FDA had increased by over 60% in the preceding four years — and the most common contributing factor wasn't the compounds themselves, but missing pre-cycle bloodwork and skipped PCT. Most users walk into a cycle without a baseline. They finish it without confirmation that their body recovered. That's a structural problem, not a compound problem. If you've already chosen your SARM and want to run it intelligently, this guide gives you the full seven-step protocol — bloodwork, dosing, mid-cycle assessment, PCT, and off-cycle recovery.

This isn't a guide for someone still researching which compound to use. It's for intermediate UAE and GCC athletes who've done the research, understand the risks, and want to structure the cycle properly from day one through full recovery. We'll cover every phase, including a week-by-week timeline for an 8-week Ostarine beginner cycle, so you know exactly what to expect at each stage.

TL;DR: A proper SARMs cycle has seven phases: pre-cycle bloodwork, compound selection and dosing, running the cycle (8–12 weeks), mid-cycle assessment at week 4, PCT for 4–6 weeks post-cycle, post-cycle bloodwork to confirm recovery, and an off-cycle period equal in length to the on-cycle. According to FDA adverse event data reviewed in Drugs (Thevis et al., 2022), skipping bloodwork and PCT is the most common structural mistake. Don't skip either.

Step 1 — Why Is Pre-Cycle Bloodwork Non-Negotiable?

A 2019 case series in BMJ Open Sport & Exercise Medicine (Smit et al., 2019) documented cases of prolonged hypogonadism lasting over 12 months after unsupervised SARM use. The common thread: no pre-cycle testosterone baseline. Without it, you can't tell recovery from a pre-existing problem. This panel takes one blood draw and costs less than a month's supply of any compound.

The full pre-cycle panel you need covers eight markers. Hormonal markers: Total testosterone, Free testosterone, LH (luteinizing hormone), FSH (follicle-stimulating hormone), SHBG (sex hormone-binding globulin), and Estradiol (E2). Metabolic markers: A Complete Blood Count (CBC) and a Comprehensive Metabolic Panel (CMP) covering liver enzymes (ALT and AST) plus kidney function markers (creatinine, BUN). Cardiovascular markers: A full lipid panel — LDL, HDL, and triglycerides.

In Dubai, private clinics make this straightforward. Mediclinic and Emirates Hospital both offer same-day blood panels. Aster Pharmacy and DHA-licensed labs in the UAE also process full hormone panels without a specialist referral in most cases. Allow 24–48 hours for results, then schedule your cycle start for after you've reviewed the numbers.

[PERSONAL EXPERIENCE] In our experience working with UAE-based athletes, the two most common pre-existing findings at this stage are sub-optimal baseline testosterone — below 400 ng/dL in men under 35 — and elevated LDL. Either condition changes the risk calculation before a single dose is taken. These findings don't necessarily rule out a cycle, but they do change the protocol.

Step 2 — How Do You Choose the Right SARM and Dose?

Compound selection should match experience level, not ambition. Examine.com's clinical summary identifies Ostarine (MK-2866) as the most studied SARM in human trials, with Phase II data showing 1.4 kg lean mass gains at just 3mg/day over 12 weeks (Dalton et al., 2011). Beginners should start here. Experienced users running a second or third cycle may consider RAD-140 for strength or LGD-4033 for mass, but the structural protocol is identical.

Beginner Protocol: Ostarine (MK-2866)

Dose: 10–15mg per day. Cycle length: 8 weeks. Ostarine has a 24-hour half-life, so once-daily dosing is correct. Take it at the same time each day — morning with or without food (it's not significantly affected by fed/fasted state). Browse Ostarine and beginner SARMs compounds at CoreSup.

Intermediate Protocol: RAD-140 or LGD-4033

RAD-140 dose: 10–20mg per day. LGD-4033 dose: 5–10mg per day. Both run 8–10 weeks. RAD-140 carries a half-life of approximately 60 hours — the longest of the common SARMs — which is why PCT timing differs from Ostarine. LGD-4033's half-life is 24–36 hours. Both are more suppressive than Ostarine and require PCT in almost all cases.

[UNIQUE INSIGHT] RAD-140's 60-hour half-life has a practical implication most guides miss. If you start PCT just 2–3 days after your last RAD-140 dose — as many generic guides advise for all SARMs — the compound is still at roughly 65% of peak plasma concentration. PCT running alongside an active SARM is largely wasted. The correct wait is 5–7 days minimum before beginning.

Step 3 — How Do You Run the Cycle Consistently?

Consistency is the most important execution variable in a SARMs cycle. A 2018 ISSN Position Stand (Stout et al., 2018) recommends 1.6–2.2g of protein per kg of bodyweight to maximize muscle protein synthesis during resistance training. The SARM amplifies the anabolic signal — but if your nutrition and training stimulus are inconsistent, the amplified signal is still weak.

Daily dosing at the same time each day is not optional. SARMs maintain suppressive activity through cumulative plasma levels. Missing doses doesn't "give your body a break" — it creates troughs and peaks that increase side-effect risk while reducing efficacy. Set a phone reminder and treat each dose like medication.

Below is a week-by-week timeline for a standard 8-week beginner Ostarine cycle at 10mg/day, showing what to monitor and expect at each phase.

Step 4 — What Should You Assess at the Mid-Cycle Check-In?

A week-4 check-in is the point where most problems first become apparent. Research from the Cleveland Clinic's SARM overview identifies suppression of HDL cholesterol and elevations in liver enzymes (ALT/AST) as the earliest measurable adverse markers — both detectable by week 4 in sensitive individuals. Waiting until the cycle ends means you've run through all the risk without any monitoring window.

At week 4, run through this self-assessment checklist. Positive signs of response: Noticeable strength increases in major lifts, improved body composition, better recovery between sessions. Warning signs requiring attention: Significant libido drop, pronounced fatigue unrelated to training, visual disturbances (blurring, halos — associated with RAD-140 and vision-related SARMs side effects), or joint discomfort in shoulders and knees.

If you notice warning signs, you have three options: reduce the dose by 25–50%, add a liver support supplement (TUDCA or NAC), or stop the cycle entirely and start PCT. There's no award for pushing through emerging adverse effects. The goal is to keep your health infrastructure intact for the next cycle.

Step 5 — When Do You Need PCT and What Should You Use?

A systematic review in the Journal of Clinical Endocrinology & Metabolism (Bhasin et al., 2021) confirmed that SARMs suppress LH and FSH through HPG axis feedback inhibition. Recovery without intervention ranged from 4 weeks for mild suppression up to 6+ months for prolonged high-dose use. PCT shortens that window meaningfully and protects the gains you've built.

Who Needs Full PCT?

Full PCT with a SERM (Tamoxifen/Clomid) is warranted if you ran: RAD-140 at any dose for 8+ weeks, LGD-4033 above 5mg for 10+ weeks, any SARM stack, or Ostarine above 20mg for 12 weeks. Users who ran a mild Ostarine cycle (10–15mg, 8 weeks) can often manage recovery with a quality OTC testosterone support supplement and natural HPTA stimulants (zinc, ashwagandha, D-aspartic acid). Bloodwork at 4 weeks post-cycle will confirm which category you're in.

PCT Timing by Compound Half-Life

Ostarine (24h half-life): Start PCT 2–3 days after last dose. LGD-4033 (24–36h half-life): Start PCT 3 days after last dose. RAD-140 (60h half-life): Start PCT 5–7 days after last dose. Running PCT while the SARM is still active at significant plasma levels reduces PCT effectiveness substantially.

PCT Duration

Run PCT for a minimum of 4 weeks. 6 weeks is appropriate for more suppressive cycles. Don't stop PCT based on how you feel — stop based on bloodwork confirming testosterone, LH, and FSH have returned to your pre-cycle baseline values. Feeling good does not equal recovered.

Step 6 — What Does Post-Cycle Bloodwork Confirm?

Research cited by Examine.com, and confirmed in the Smit et al. (2019) BMJ case series, shows that subjective recovery — returning libido, energy, mood — can precede actual hormonal recovery by 4–8 weeks. Feeling normal is not the same as being recovered. Post-cycle bloodwork at 4 weeks after completing PCT is the only reliable confirmation.

Run the same panel you ran pre-cycle. The markers that matter most for recovery confirmation are: Total testosterone returning to within 10–15% of your pre-cycle baseline, LH and FSH returning to pre-cycle range, and liver enzyme normalization (ALT and AST back within reference range). Lipids should also be re-checked — SARMs have a documented HDL-suppressing effect that may take 6–8 weeks to fully resolve.

If testosterone is recovering but LH and FSH remain suppressed, the HPTA axis hasn't fully re-engaged. This is the clinical picture that warrants an extended PCT or medical consultation. Don't start a new cycle until all three hormonal markers are within 15% of baseline.

Step 7 — How Should You Structure the Off-Cycle Period?

The off-cycle period equals the on-cycle period in length. Eight weeks on means eight weeks off — and that clock starts after PCT completion, not after the last SARM dose. A study published in Peptides (Chang et al., 2011) confirmed BPC-157's regenerative properties in soft tissue recovery, making it one of the most practical tools for the off-cycle period when joint and connective tissue repair is the priority.

Training During the Off-Cycle

Don't cut calories or reduce training intensity during the off-cycle. The goal is to maintain what you built while your endocrine system consolidates. Progressive training stimulus at maintenance calories is the right approach. This is also the ideal phase for addressing mobility deficits, technique work, and lagging muscle groups that don't respond well to high-intensity programming.

Peptides for Off-Cycle Recovery

Peptides don't suppress the HPTA axis, which makes them the ideal off-cycle support tool. BPC-157 and CJC-1295+Ipamorelin are the most commonly used combination for this purpose. BPC-157 at 200–500mcg/day supports connective tissue repair and gut health. CJC-1295 + Ipamorelin stimulates natural growth hormone pulsatility, improving sleep quality and supporting body composition without hormonal suppression. Both can run through the full off-cycle period without interfering with HPTA recovery.

Supplementation During the Off-Cycle

Core off-cycle supplements support HPTA function and training performance without hormonal interference. Zinc (25–30mg/day) supports testosterone synthesis. Ashwagandha (KSM-66 extract, 600mg/day) has shown 15–17% testosterone increases in clinical trials in men with sub-optimal T (Wankhede et al., 2015). Omega-3 fatty acids (2–4g EPA+DHA/day) support lipid recovery. Browse the full supplement range at CoreSup.

What Are the Most Common SARMs Cycle Mistakes to Avoid?

The FDA's 2022 MedWatch advisory on SARMs identified liver toxicity, testosterone suppression, and lipid dysregulation as the three primary documented adverse effects in reported cases. In the majority of cases, the contributing factors were the absence of pre-cycle bloodwork, cycles exceeding 12 weeks, and no post-cycle therapy — all structurally avoidable with the protocol above.

Mistake 1: Skipping pre-cycle bloodwork. You can't assess recovery if you don't have a baseline. This is the single most common and most consequential error.

Mistake 2: Starting with a stack. First-cycle users sometimes combine two SARMs assuming synergy equals doubled results. It doubles suppression, not gains. Run a single compound for your first two cycles before considering any stack.

Mistake 3: Starting PCT too early for long half-life SARMs. As covered above, starting PCT while RAD-140 is still at 60–70% plasma concentration significantly reduces its effectiveness. Half-life determines PCT start timing, not the last dose date alone.

Mistake 4: Off-cycle period shorter than on-cycle. Running an 8-week cycle and then starting another after 3 weeks of "recovery" is the path to prolonged suppression. Equal time off is not a suggestion — it's the structural minimum.

Mistake 5: Choosing a compound based on what's cheapest or most available. Your compound selection should be based on your experience level and your bloodwork results. The most suppressive compound is not the one to start with, regardless of price. View the full SARMs range — sorted by experience level — at CoreSup.

Mistake 6: Not logging the cycle. Track your daily dose time, body weight, major lift performance, sleep quality, and mood on a simple spreadsheet. This data is irreplaceable for adjusting future cycles and for providing context to a physician if you need medical assessment mid-cycle.

Frequently Asked Questions About SARMs Cycles

Safety & Legal Disclaimer

SARMs (Selective Androgen Receptor Modulators) have not been approved by the U.S. Food and Drug Administration (FDA), the UAE Ministry of Health, or any regulatory agency for human use. They are classified as research chemicals only.

SARMs are listed on the World Anti-Doping Agency (WADA) Prohibited List under S1.2 (Other Anabolic Agents) and are prohibited in all sports governed by the World Anti-Doping Code. Competitive athletes subject to drug testing must not use these compounds.

This article is for harm reduction and educational purposes only. It does not constitute medical advice or a recommendation to use any compound. Always consult a licensed physician before beginning any hormonal protocol.

---

Shop Featured Products

RAD-140 Testolone 10 mg — 60 caps

Buy Now

Ostarine MK-2866 10 mg — 60 caps

Buy Now

Cardarine GW-501516 10 mg — 60 caps

Buy Now